| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161529776P | 2011-08-31 | 2011-08-31 | |
| PCT/US2012/053142WO2013033398A1 (en) | 2011-08-31 | 2012-08-30 | Engineered sequences to facilitate expression of antigens in neisseria and methods of use |
| Publication Number | Publication Date |
|---|---|
| SG11201400199XAtrue SG11201400199XA (en) | 2014-03-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400199XASG11201400199XA (en) | 2011-08-31 | 2012-08-30 | Engineered sequences to facilitate expression of antigens in neisseria and methods of use |
| Country | Link |
|---|---|
| US (1) | US9260489B2 (en) |
| EP (1) | EP2750702A4 (en) |
| JP (1) | JP2014529407A (en) |
| KR (1) | KR20140064922A (en) |
| CN (1) | CN103906534A (en) |
| AU (1) | AU2012301812A1 (en) |
| BR (1) | BR112014004606A2 (en) |
| CA (1) | CA2846290A1 (en) |
| MX (1) | MX2014002375A (en) |
| RU (1) | RU2014112052A (en) |
| SG (1) | SG11201400199XA (en) |
| WO (1) | WO2013033398A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9657297B2 (en)* | 2012-02-02 | 2017-05-23 | Glaxosmithkline Biologicals Sa | Promoters for increased protein expression in meningococcus |
| LT3110442T (en) | 2014-02-28 | 2020-12-28 | Glaxosmithkline Biologicals Sa | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES |
| GB201522153D0 (en) | 2015-12-15 | 2016-01-27 | Univ Southampton | Meningococcal infection and modified neisseria lactamica |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| EP4188436A4 (en)* | 2020-07-30 | 2024-10-09 | Omvax, Inc. | Sars-cov-2 receptor binding domain in native outer membrane vesicles |
| CN119331872B (en)* | 2024-12-23 | 2025-04-08 | 上海羽冠生物技术有限公司 | A promoter and its application in enhancing the expression of meningococcal protein |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9910089A (en) | 1998-05-01 | 2004-06-08 | Chiron Corp | Compositions and antigens of neisseria meningitidis |
| US20070026021A1 (en) | 1998-05-01 | 2007-02-01 | Chiron S.R.I. | Neisseria meningitidis antigens and compositions |
| WO2001034642A2 (en) | 1999-11-12 | 2001-05-17 | University Of Iowa Research Foundation | Control of neisserial membrane synthesis |
| CN1201011C (en) | 2000-02-28 | 2005-05-11 | 启龙股份公司 | Heterologous expression of neisserial proteins |
| GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| US7495092B2 (en) | 2005-01-14 | 2009-02-24 | North Carolina State University | Compositions comprising promoter sequences and methods of use |
| WO2009038889A1 (en) | 2007-08-02 | 2009-03-26 | Children's Hospital And Research Center At Oakland | Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| RU2477145C2 (en) | 2008-05-30 | 2013-03-10 | ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ | Multivalent vaccine of native vesicles of meningococcal outer membrane, method for making and using it |
| GB0816447D0 (en) | 2008-09-08 | 2008-10-15 | Glaxosmithkline Biolog Sa | Vaccine |
| Publication number | Publication date |
|---|---|
| MX2014002375A (en) | 2014-09-15 |
| US20140220632A1 (en) | 2014-08-07 |
| BR112014004606A2 (en) | 2017-03-21 |
| JP2014529407A (en) | 2014-11-13 |
| CN103906534A (en) | 2014-07-02 |
| CA2846290A1 (en) | 2013-03-07 |
| AU2012301812A1 (en) | 2014-03-06 |
| RU2014112052A (en) | 2015-10-10 |
| EP2750702A1 (en) | 2014-07-09 |
| EP2750702A4 (en) | 2015-03-04 |
| WO2013033398A1 (en) | 2013-03-07 |
| KR20140064922A (en) | 2014-05-28 |
| US9260489B2 (en) | 2016-02-16 |
| Publication | Publication Date | Title |
|---|---|---|
| IL282219B (en) | Human antibodies to pcsk9 for use in methods of treating particular groups of subjects | |
| EP2795570A4 (en) | Using photograph to initiate and perform action | |
| ZA201308461B (en) | Multiple antigen presenting immunogenic composition and methods and uses thereof | |
| ZA201308022B (en) | Anti-cd40 antibodies and methods of use | |
| ZA201403760B (en) | Anti-cd98 antibodies and methods of use thereof | |
| ZA201404962B (en) | Modified mini-hepcidin peptides and methods of using thereof | |
| IL232055B (en) | Anti-htra1 antibodies and methods of use | |
| IL236738A0 (en) | Human antibodies to gfrɑ3 and methods of use thereof | |
| SMT201900595T1 (en) | Transdermal compositions of ibuprofen and methods of use thereof | |
| GB201411462D0 (en) | Prebiotic formulations and methods of use | |
| SG11201400199XA (en) | Engineered sequences to facilitate expression of antigens in neisseria and methods of use | |
| GB2492147B (en) | Improvements in and relating to mattresses | |
| GB2495816B (en) | Improvements in or relating to arborists' clamps and methods of using them | |
| GB201120244D0 (en) | Improvements in and relating to files | |
| PT3301107T (en) | Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment | |
| GB201203402D0 (en) | Improvements in and relating to manipulation of fasteners | |
| GB201216724D0 (en) | Note pad and method of use thereof | |
| GB201119201D0 (en) | Improvements to inflatable advertisement means and method of use thereof | |
| PT3395836T (en) | Human antibodies to pcsk9 for use in methods of treating particular groups of subjects | |
| GB201104729D0 (en) | Improvements to inflatable advertisement means and method of use thereof | |
| GB201110628D0 (en) | Improvements in and relating to mattresses |